Ethicon Inc.
From Wikipedia, the free encyclopedia
Ethicon, Inc. is a subsidiary of Johnson & Johnson. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line.
Ethicon has been the world leader in manufacturing of surgical sutures and wound closure devices for over a century. After World War II, Ethicon’s market share in surgical sutures rose from 15% to 70% worldwide. In the United States, the market share is approximately 80%.
Ethicon is headquartered in Somerville, New Jersey. It currently conducts business in 52 countries and employs approximately 11,000 people.
In 1992, Ethicon was restructured, and Ethicon Endo-Surgery, Inc. became a separate corporate entity.
During the 1990s, Ethicon diversified into new and advanced products and technologies and formed four different companies under the Ethicon umbrella, each of which specialize in different products.
[edit] Ethicon Companies
- ETHICON products: suture products and suture technology
- GYNECARE: women's health products
- Johnson & Johnson Wound Management: skin and wound care
- CARDIOVATIONS: cardiovascular products that restore and improve the circulatory health and quality of life for people with cardiovascular disease
| Johnson & Johnson | |
|---|---|
| William C. Weldon, Chairman & CEO | |
| Past CEOs and Presidents: Robert Wood Johnson I • James Wood Johnson • Robert Wood Johnson II • Robert Wood Johnson III • Philip B. Hofmann • Richard B. Sellars • James E. Burke • Ralph S. Larsen | |
| Selected Subsidiaries | |
| ALZA Corporation • Centocor • Cilag • DePuy, Inc. • Ethicon Endo-Surgery, Inc. • Ethicon, Inc. • Independence Technology, LLC • Janssen Pharmaceutica • LifeScan • McNeil Consumer & Specialty Pharmaceuticals • Ortho-McNeil Pharmaceutical • Ortho-Neutrogena • Penaten • Tibotec | |
| Selected Brands | |
| Acuvue • Aveeno • Band-Aid • Carefree • Clean & Clear • Johnson's Baby • K-Y • Neutrogena • OneTouch • Rembrandt • Stayfree • Tylenol | |
Annual Revenue: $53.3 billion USD  5.6% Annual Income: $11.1 billion USD 9.9% (FY 2006) | Employees: 116,200 | Stock Symbol: NYSE: JNJ | Website: www.jnj.com |
|
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
